Teva Pharmaceutical Industries LimitedTEVANYSE
LOADING
|||
Key Metrics
As of 2024• vs 2023
Per Share
Revenue/Share
$14.63+3.2%
Net Income/Share
$-1.45-189.8%
Operating CF/Share
$1.10-9.9%
Free CF/Share
$0.66-12.1%
Cash/Share
$2.92+1.1%
Book Value/Share
$5.06-30.4%
Tangible Book/Share
$-12.24+5.2%
Equity/Share
$4.75-29.2%
Interest Debt/Share
$16.87-11.0%
Valuation
Market Cap
$25.24B+113.4%
Enterprise Value
P/E Ratio$40.02B+39.2%
-15.40+27.2%
P/S Ratio1.53+104.4%
P/OCF Ratio
20.24+134.1%
P/FCF Ratio
P/B Ratio33.70+139.9%
4.70+198.2%
P/TB Ratio
EV/Sales4.70+198.2%
2.42+33.3%
EV/EBITDA
51.51+179.1%
Profitability
Earnings Yield-6.49%-37.4%
FCF Yield2.97%-58.3%
ROE-30.50%-309.6%
ROIC-1.63%-225.5%
Return on Tangible Assets-8.29%-210.3%
Capital Allocation
CapEx/OCF
39.94%+3.9%
CapEx/Revenue
3.01%-9.3%
CapEx/Depreciation
0.47+3.1%
SBC/Revenue
0.74%-2.6%
Balance Sheet
Debt/Equity3.36+25.3%
Debt/Assets0.46-0.8%
Net Debt/EBITDA
Current Ratio19.02+75.1%
0.98-3.8%
Interest Coverage-0.30x-171.9%
Income Quality-0.64+74.0%
Efficiency
Days Sales Outstanding
67 days-14.0%
Days Payables Outstanding
95 days-18.1%
Days Inventory
129 days-27.7%
Receivables Turnover
5.41x+16.3%
Payables Turnover
3.85x+22.2%
Inventory Turnover
2.82x+38.3%
Special Valuations
Graham Number
--
Graham Net-Net
$-23.44+4.9%